Optimal Duration of Treatment for HCV Genotype 1 Infection in Slow Responders: A Meta-Analysis

BACKGROUND: A head-to-head comparison of the 72-week and 48-week anti-HCV therapies in slow responders with genotype 1 infection has been performed in several randomized clinical trials (RCTs). OBJECTIVES: This review aimed at summarizing and pooling the results of these studies. MATERIALS AND METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Alavian, Seyed Moayed, Tabatabaei, Seyed Vahid, Behnava, Bita, Mahboobi, Nastaran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2011
Materias:
Meta Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227488/
https://www.ncbi.nlm.nih.gov/pubmed/22140384
http://dx.doi.org/10.5812/kowsar.1735143X.721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227488/
https://www.ncbi.nlm.nih.gov/pubmed/22140384
http://dx.doi.org/10.5812/kowsar.1735143X.721

Ejemplares similares